Syringomyelia
13
4
5
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Genetic Analysis of the Chiari I Malformation
A Prospective Natural History Study of Patients With Syringomyelia
Extracellular Vesicles for the Treatment of Syringomyelia
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia
The Therapeutic Effect of Betaine in Syringomyelia
The Therapeutic Effect of Thalidomide in Syringomyelia
Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia
Impact of Peripheral Afferent Input on Central Neuropathic Pain
Investigation of the Effects of Exercise on Patients With Chiari Malformation
Clinical Trial of a Serious Game for Individuals With SCI/D
Study and Surgical Treatment of Syringomyelia
Establishing the Physiology of Syringomyelia